LATEST NEWS

NBTXR3 activated by radiotherapy in combination with nivolumab or pembrolizumab in patients with advanced cancers: results from an ongoing dose escalation phase I trial (Study 1100)

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.